Home
›
Damora Therapeutics, Inc.
› SCHEDULE 13G/A Apr 23, 2026
Damora Therapeutics, Inc. (DMRA): SCHEDULE 13G/A filed Apr 23, 2026
Form type
SCHEDULE 13G/A
Filing date
Apr 23, 2026
Accession number
0001193125-26-174461
Filer
Damora Therapeutics, Inc.
(CIK 1800315)